Sinupret w leczeniu zapalenia zatok przynosowych Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2019
Słowa kluczowe:
zapalenie zatok przynosowych, dzieci, dorośli, leki ziołowe, skuteczność, bezpieczeństwo
##plugins.themes.bootstrap3.article.main##
Abstrakt
W EPOS 2012 zawarte są rekomendacje do stosowania w zapaleniu zatok przynosowych produktów o działaniu sekretolitycznym, immunomodulującym, przeciwzapalnym, przeciwwirusowym i przeciwbakteryjnym. Lek Sinupret charakteryzują wymienione właściwości. W artykule przedstawiono dane z piśmiennictwa światowego potwierdzającego skuteczność i bezpieczeństwo jego stosowania w ostrym i przewlekłym zapaleniu zatok przynosowych u dzieci i dorosłych.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Jurkiewicz , D., & Zielnik-Jurkiewicz , B. (2019). Sinupret w leczeniu zapalenia zatok przynosowych . Medycyna Faktów , 12(3(44), 250-255. https://doi.org/10.24292/01.MF.0319.11
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Fokkens W.J., Lund V.J., Mullol J. et al.: EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; 50(1): 1-12.
2. Oliff H.S., Blumentahl M.: Proprietary Botanical Product, Scientific and Clinical Monograph for Sinupret. American Botanical Council [online: www. herbalgram.org].
3. Virgin F., Zhang S., Schuster D. et al.: The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo. Laryngoscope 2010; 120(5): 1051-1056.
4. Rossi A., Dehm F., Kiesselbach C.: The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo. Fitoterapia 2012; 83(4): 715-720.
5. Kreindler J.L., Chen B., Kreitman Y. et al.: The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am. J. Rhinol. Allergy 2012; 26(6): 439-443.
6. Glatthaar-Saalmüller B., Rauchhaus U., Rode S.: Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections. Phytomed. 2011; 19(1): 1-7.
7. Werz O., Seifert S., Wosikowski K. et al.: Anti-viral and anti-inflammatory efficacies of Sinupret® dry extract BNO 1011 rationalize its therapeutic use in acute rhinosinusitis. Planta Med. 2013: 79-84.
8. Schmidt W.: Treatment of sinusitis in childhood. Fortschr. Med. 1975; 93(31): 1567-1569.
9. Tarasova G.D.: The administration of sinupret in the treatment of acute sinusitis in children. Vestn. Otorinolaringol. 2001; (2): 46-48.
10. Dzhaparidze S.V., Gegenava Kh.A., Dzhashi M.M. et al.: Estimation of effectiveness of peroral mucolytic agents in treatment of inflammatory diseases of middle ear and paranasal sinusitis. Georgian Med. News 2007; 145: 36-38.
11. Biebach K., Kramer A.: Effective treatment of rhinosinusitis in children. Praktische Pädiatrie 2004; 10: 333-336.
12. Popovic V.I., Koshel I.V.: Sinupret® as add-on therapy to saline irrigation for children with acute Post-Viral Rhinosinusitis. Clinical Phytoscience 2017; 3: 10-16.
13. Passali D., Loglisci M., Passali G.C. et al.: A prospective open-label study to assess the efficacy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis. ORL J. Otorhinolaryngol. Relat. Spec. 2015; 77(1): 27-32.
14. Jund R., Mondigler M., Steindl H. et al.; ARhiSi II study group: Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology 2012; 50(4): 417-426.
15. Jund R., Mondigler M., Steindl H. et al.: Clinical efficacy of a herbal drug combination in acute viral rhinosinusitis. MMW Fortschr. Med. 2015; 157: 6-11.
16. Jund R., Mondigler M., Stammer H. et al.: Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015; 135(1): 42-50.
17. Melzer J., Saller R., Schapowal A. et al.: Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch. Komplementmed. 2006; 13(2): 78-87.
18. Bachert C., Mondigler M., Steindl H. et al.: Multicentre, randomised, double-blind, placebo-controlled, parallel-group dose-finding study of herbal medicine (dry extract) BNO 1016 in acute rhinosinusitis (ARhiSi-1). 84th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery 2013.
19. Neubauer N., März R.W.: Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar-coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomed. 1994; 1: 177-181.
20. Braum D., März R.W.: Randomised, open comparative study of Sinupret versus N-acetylcysteine in cases of sinusitis. Neu-markt, Germany. Bionorica 1990.
21. Kraus P., Schwender W.: Randomized, open comparative study with Sinupret sugar-coated tablets vs. GeloMyrtol F. conducted at the Germany Army Hospital in Amberg. Paper presented at: 4th and international Congress on Phytotherapy 1992; Munich, Germany.
22. Peric A., Vezmar Kovacevic S., Gacesa D. et al.: Efficacy and safety of combined treatment of acute rhinosinusitis by herbal medicinal product Sinupret and mometasone furoate nasal spray. ENT Updates 2017; 7(2): 68-74.
23. Ismail C.: Recent results on the rational for the Sinupret compound. HNO 2005; 53(1): S38-42.
24. Reden J., El-Hifnawi D., Zahnert T. et al.: The effect of a herbal combination of primrose, gentian root, vervain, elder flowers, and sorrel on olfactory function in patients with a sinonasal olfactory dysfunction. Rhinology 2011; 49(3): 342-346.
25. Melzer J., Saller R., Schapowa A. et al.: Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplementmed 2006; 13: 78-87.
26. Richstein A., Mann W.: Treatment of chronic rhino-sinusitis with Sinupret. Schewiz. Zschr. GanzheitsMedizin 1999; 11: 280-283.
27. Palm J., Steiner I., Abramov-Sommariva D.: Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis. Rhinology 2017; 55(2): 142-151.
28. Koch A.K., Klose P., Lauche R.: A Systematic Review of Phytotherapy for Acute Rhinosinusitis. Forsch. Komplementmed. 2016; 23: 165-169.
2. Oliff H.S., Blumentahl M.: Proprietary Botanical Product, Scientific and Clinical Monograph for Sinupret. American Botanical Council [online: www. herbalgram.org].
3. Virgin F., Zhang S., Schuster D. et al.: The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo. Laryngoscope 2010; 120(5): 1051-1056.
4. Rossi A., Dehm F., Kiesselbach C.: The novel Sinupret® dry extract exhibits anti-inflammatory effectiveness in vivo. Fitoterapia 2012; 83(4): 715-720.
5. Kreindler J.L., Chen B., Kreitman Y. et al.: The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am. J. Rhinol. Allergy 2012; 26(6): 439-443.
6. Glatthaar-Saalmüller B., Rauchhaus U., Rode S.: Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infections. Phytomed. 2011; 19(1): 1-7.
7. Werz O., Seifert S., Wosikowski K. et al.: Anti-viral and anti-inflammatory efficacies of Sinupret® dry extract BNO 1011 rationalize its therapeutic use in acute rhinosinusitis. Planta Med. 2013: 79-84.
8. Schmidt W.: Treatment of sinusitis in childhood. Fortschr. Med. 1975; 93(31): 1567-1569.
9. Tarasova G.D.: The administration of sinupret in the treatment of acute sinusitis in children. Vestn. Otorinolaringol. 2001; (2): 46-48.
10. Dzhaparidze S.V., Gegenava Kh.A., Dzhashi M.M. et al.: Estimation of effectiveness of peroral mucolytic agents in treatment of inflammatory diseases of middle ear and paranasal sinusitis. Georgian Med. News 2007; 145: 36-38.
11. Biebach K., Kramer A.: Effective treatment of rhinosinusitis in children. Praktische Pädiatrie 2004; 10: 333-336.
12. Popovic V.I., Koshel I.V.: Sinupret® as add-on therapy to saline irrigation for children with acute Post-Viral Rhinosinusitis. Clinical Phytoscience 2017; 3: 10-16.
13. Passali D., Loglisci M., Passali G.C. et al.: A prospective open-label study to assess the efficacy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis. ORL J. Otorhinolaryngol. Relat. Spec. 2015; 77(1): 27-32.
14. Jund R., Mondigler M., Steindl H. et al.; ARhiSi II study group: Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology 2012; 50(4): 417-426.
15. Jund R., Mondigler M., Steindl H. et al.: Clinical efficacy of a herbal drug combination in acute viral rhinosinusitis. MMW Fortschr. Med. 2015; 157: 6-11.
16. Jund R., Mondigler M., Stammer H. et al.: Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015; 135(1): 42-50.
17. Melzer J., Saller R., Schapowal A. et al.: Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch. Komplementmed. 2006; 13(2): 78-87.
18. Bachert C., Mondigler M., Steindl H. et al.: Multicentre, randomised, double-blind, placebo-controlled, parallel-group dose-finding study of herbal medicine (dry extract) BNO 1016 in acute rhinosinusitis (ARhiSi-1). 84th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery 2013.
19. Neubauer N., März R.W.: Placebo-controlled, randomized double-blind clinical trial with Sinupret sugar-coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomed. 1994; 1: 177-181.
20. Braum D., März R.W.: Randomised, open comparative study of Sinupret versus N-acetylcysteine in cases of sinusitis. Neu-markt, Germany. Bionorica 1990.
21. Kraus P., Schwender W.: Randomized, open comparative study with Sinupret sugar-coated tablets vs. GeloMyrtol F. conducted at the Germany Army Hospital in Amberg. Paper presented at: 4th and international Congress on Phytotherapy 1992; Munich, Germany.
22. Peric A., Vezmar Kovacevic S., Gacesa D. et al.: Efficacy and safety of combined treatment of acute rhinosinusitis by herbal medicinal product Sinupret and mometasone furoate nasal spray. ENT Updates 2017; 7(2): 68-74.
23. Ismail C.: Recent results on the rational for the Sinupret compound. HNO 2005; 53(1): S38-42.
24. Reden J., El-Hifnawi D., Zahnert T. et al.: The effect of a herbal combination of primrose, gentian root, vervain, elder flowers, and sorrel on olfactory function in patients with a sinonasal olfactory dysfunction. Rhinology 2011; 49(3): 342-346.
25. Melzer J., Saller R., Schapowa A. et al.: Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplementmed 2006; 13: 78-87.
26. Richstein A., Mann W.: Treatment of chronic rhino-sinusitis with Sinupret. Schewiz. Zschr. GanzheitsMedizin 1999; 11: 280-283.
27. Palm J., Steiner I., Abramov-Sommariva D.: Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis. Rhinology 2017; 55(2): 142-151.
28. Koch A.K., Klose P., Lauche R.: A Systematic Review of Phytotherapy for Acute Rhinosinusitis. Forsch. Komplementmed. 2016; 23: 165-169.